Nikkei snaps five days of gains as U.S. inflation data looms



TOKYO, June 10 (Reuters) - Japan's Nikkei share average snapped a five-session winning run on Friday, tracking Wall Street's plunge overnight as investors braced for key U.S. inflation data that will guide the Federal Reserve's policy tightening path.

The Nikkei .N225 fell 1.49% to 27,824.29, slipping below the key psychological level of 28,000 and retreating from a near five-month peak of 28,389.75 hit on Thursday. But the benchmark rose 0.23% this week in its fourth straight weekly gain.

The broader Topix .TOPX dropped 1.32% to 1,943.09, but rose 0.51% for the week.

Overnight, the tech-heavy Nasdaq .NDX slumped 2.74% and the S&P 500 eased 2.38%. The market is expecting strong May consumer price data, which would back the case for aggressive Federal Reserve policy tightening even at the risk of choking economic growth.

Japanese investors worried the CPI data would send U.S. stocks lower and that they would not be able to react until markets in Tokyo reopen on Monday, said a market participant with a domestic securities company.

A market participant from another Japanese securities firm said it's a day when nerves were elevated.

Growth shares including technology firms lagged, with the Topix's growth index .TOPXG sliding 1.73%, versus a 0.95% drop for the value index .TOPXV .

Chip-testing equipment maker Advantest 6857.T slumped 4.2% and chip-making equipment giant Tokyo Electron 8035.T dropped 3.22%.

Uniqlo store operator Fast Retailing 9983.T and tech investor SoftBank Group 9984.T skidded 0.93% and 2.01%, respectively.

All the 33 industry sub-indexes on the Tokyo Stock Exchange fell, with machinery makers .IMCHN.T shedding 2.14% to become the worst sector.

Of the Nikkei's 225 component stocks, 189 fell versus 34 that rose.
Reporting by Tokyo markets team; Editing by Sherry Jacob-Phillips and Subhranshu Sahu

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.